Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
Redox regulation, Oxidative Stress and Selenoproteins
Redox and Protein Folding
Danyelle M. Townsend May 18 – 22, 2015
Charleston, SC
Endoplasmic Reticulum (ER)���Albert Claude 1945���
Lace work structure”
Rough ER
• Protein synthesis: Secreted,
membrane bound, digestive enzymes, hormones and antibodies
• Translocon docking sites for ribosome
• GSH/ GSSG ~10:1
Smooth ER:
• Lipid / phospholipid and
steroid synthesis
• Calcium ion storage
Sarcoplasmic ER:
Calcium storage: major role in excitation / contraction coupling
Demand exceeds capacity ……..
Conditions
Probable effects
temperature shifts
(e.g., heat-shock)
protein denaturation
protein aggregation
heavy metals, arsenite, iodoacetamide
reaction with sulfhydryl goups, conformational changes in protein
anoxia, hydrogen peroxide, superoxide ions, free radicals
oxygen toxicity, free radical fragmentation of proteins
proteasome inhibitors
inhibition of proteolysis
amytal, azide, dinitrophenol, ionophores
antimycin
inhibition of oxidative phosphorylation, changes in redox state,
covalent modification of proteins
hydroxylamine
cleavage of asparagine-glycine bonds
ethanol
translation errors
amino acid analogs, puromycin
abnormal proteins
Agents/Treatments that induce ER stress response
Grek and Townsend (2013): ER stress and Cancer Biology:
Misfolded protein"
Retrograde transport "through the translocon "
Ubiquitination"
Degradation in the"26S proteasome"
ERAD"
Sec proteins and ER export
Adapted from www.arthritis-research.com
Zhang, K. et al. J. Biol. Chem. 2004
Three UPR transducers and one master regulator GRP78 / BiP: Glucose related protein / Binding Immunoglobin Protein
Zhang, K. et al. J. Biol. Chem. 2004;279:25935-25938
UPR signaling mediated by PERK protein kinase RNA-like endoplasmic reticulum kinase
Zhang, K. et al. J. Biol. Chem. 2004
UPR signaling mediated by IRE1 and ATF6
Nature Medicine: Iwawaki et al., (2004) 10:1014
Transgenic mouse model for monitoring endoplasmic reticulum stress in vivo
Wek et al., Nature Medicine (2010) 16: 374-376
www.anti-agingfirewalls.com
Duration and amplitude of ER stress determines cell fate
Unfolded and misfolded proteins magically appear?
H2N
CH2
COOH
S.
GSH
NO
GSNO
N2O3
SSG
H2N
CH2
COOH
SH SNO
H2N
CH2
COOH
SHS-glutathionylation
GSH / Trx
GSH/ Grx / Srx
SH
SOH
ROS RNS
ROS RNS
Sulfhydryl
Cysteinyl radical
Sulfenic acid
S-nitrosylation
J. Uys, P. Mulholand, D.M. Townsend (2014) Molecular Pharmacology
GSTP S-glutathionylates ER resident proteins
Mass Spectrometry Identification of S-glutathionylated ER proteins
Protein ID MW (kDa)
Calnexin 97
Calreticulin 60
Endoplasmin 94
SERCA2A 114
GRP78, Bip 78
Protein disulfide isomerase (A5) 59
GSTP is a resident Endoplasmic Reticulum (ER) protein
BIP
GSTP
Merge - TRIO
DAPI - nuclear
Calnexin
DAPI - nuclear
GSTP
Merge - TRIO
GSTP
Calnexin
GAPDH
Gstp1/p2 + - + - + -
ER Cyto Nuc
Histone H3
SERCA2
GSTP is a resident ER Protein
GSTP regulates ER Calcium homeostasis
0%
20%
40%
60%
80%
100%
120%
0 500 1000 1500
ER
Cal
cium
hom
eost
asis
(%
of c
ontr
ol)
Time (second)
Gstp1/p2+/+ Gstp1/p2-/-
Thapsigargin Gstp1/p2+/+
Gstp1/p2-/-
GSTP interacts with ER protein
and enhances S-glutathionylation
*
* *
0
20
40
60
80
100
120
Rel
ativ
e Pr
-SSG
leve
l
WT Gstp1/p2-/-
GSTP BIP
PDI
GSTP
Calnexin
GSTP
Calreticulin GSTP
IP: Calnexin
IP: BIP
IP: Calreticulin
IP: PDI
Total IP IP IgG
Disulfiram (10µM)
- - + -
Gstp1/p2+/+
Gstp1/p2-/-
Thapsigargin (nM)
Velcade (nM)
Gstp1/p2+/+ 121.7 23.6
Gstp1/p2-/- 16.5 3.0
ratio 7.4 7.9
Thapsigargin and Velcade are more toxic to Gstp1/p2-/- BMDDCs
Viability (IC50 value)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375108/
ER dysfunction in liver disease
J Pharmacol Exp Ther. 2013 Jan;344(1):286-94. doi: 10.1124/jpet.112.199067. Epub 2012 Oct 23.���Mouse liver protein sulfhydryl depletion after acetaminophen exposure.���
Yang X, Greenhaw J, Shi Q, Roberts DW, Hinson JA, Muskhelishvili L, Davis K, Salminen WF.���Source���
Division of Systems Biology, National Center for Toxicological Research, Jefferson, Arkansas, USA.
Protein – SH depleted regions correlated with areas exhibiting histopathologic injury
NOT GLOBAL DECREASE IN LIVER
J Pharmacol Exp Ther. 2012 Feb;340(2):360-8. doi: 10.1124/jpet.111.187948. Epub 2011 Nov 1.���
Changes in mouse liver protein glutathionylation after acetaminophen exposure. ���
Yang X, Greenhaw J, Ali A, Shi Q, Roberts DW, Hinson JA, Muskhelishvili L, Beger R, Pence LM, Ando Y, Sun J, Davis K, Salminen WF.���
1h = Increased P-SSG
24h = Decreased P-SSG at site of necrosis
PROTEIN OXIDATION 10x > APAP-Conjugation
Increased resistance to acetaminophen hepatotoxicity���in mice lacking glutathione S-transferase Pi���Colin J. Henderson*, C. Roland Wolf* Neil Kitteringham,Helen Powell §, Diana Otto*, and B. Kevin
Park ������
NAPQI + GSH Detox (NOT related to GSTP)
NAPQI + Protein adduct equivalent
GSTP +/+ decreased GSH/GSSG
** Toxic role of GSTP downstream of protein conjugation of NADPQI
Decreased S-glutathionylation of BiP in GSTP1P2 knockout mouse
liver
GSTp
GAPDH
BiP
112213_SCW_II_141_Glut_BIP_FirstZT #16877 RT: 94.18 AV: 1 NL: 1.91E4F: ITMS + c NSI d Full ms2 [email protected] [220.00-1710.00]
300 400 500 600 700 800 900 1000 1100 1200 1300 1400 1500 1600 1700m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lativ
e A
bu
nd
an
ce
x5 x5
34DLGTTYSC(glut)VGVFK46
MH+ = 1694.74 Da
M+2H+ = 847.87 Da
y2
294.16
y4
450.23
b5-H2O
470.22
b4
387.23
y5
549.34
(y11-129)2+
669.46
y112+
733.98
y3
393.26
(M+2H-129-H2O)2+
774.56
(M+2H-129)2+
783.53
y6-129-H2O
810.65
(M+2H-H2O-NH3)2+
829.60
y7-129
915.44
y6
957.50
y7
1044.46
y8-129
1078.50
y8
1207.56
y9-129
1179.58
y9
1308.57
b9
1245.51
b11-129
1272.50
y11-129
1337.61
b11
1401.63
y11
1466.72
b12
1548.49
b9-129
1116.51
BiP is s-glutathionylated on C41 and C420
BiP
PSSG
Merge
HEPG2 Cells pre-treated with NAC (and treated with 15mM APAP for 16hrs) have
28% increase in GSH ���RESULTS:
0
20
40
60
80
100
120
140
160
Relative GSH concentration
* *
BiP-SSG is concurrent with APAP induced liver toxicity
• BiP: GSTpi dissociates when under ER stress
• GSTpi KO mice have 42% less SSG-BiP than GSTpi WT mice
• NAC treatment increases GSH / decreases BiP-SSG and reduces apoptosis
Protein Disulfide Isomerase
• 55 kDa Homodimer • 14 PDI isoforms in ER • Two – UPRE in promotor
– (Kox = 1mM)
• Widely distributed across eukaryotic tissues – mM Concentrations – 1% total pr. Content of cells – Decreased PDI leads to protein aggregation (ie Anti-
chaperone)
Tian et al., 2006: Cell: 14(1): 61-73
SH SH
S-----S
Disulfide Formation
Sulfydryl
Disulfide
PDI
S-S
PDI
SH SH
Disulfide Isomerizations
S-------S
S S
S S
S------S
PDI
SH SH
PABA/NO - - + + +
IP:α-PDI + - - + +
IP:IgG - + + - -
DTT
- - - - +
WB:PSSG
WB:PDI
250
105
75
50
PDI-SSG is concurrent with UPR activation
Townsend et al., Mol Pharm 2006
Townsend et al., Cancer Research 2009
Xiong et al., I J Cell Biology 2012
Grek et al., ER stress and Cancer 2014
PDI-SSG Alters Structure / Function
0
20
40
60
80
100
120
0 25 50 100Per
cent
Act
ivity
μM PABA/NO
Wavelength, nm
250 300 350 400 450 500 550
Em
ission, au
-20
0
20
40
60
80
100
120
GSTSG GST Intact
Wavelength, nm
180 200 220 240 260 280
Molecular ellipticity, C
D units
-40
-20
0
20
40
60
80
GST INTACTGSTSG
Circular Dichroism Intrinsic Fluorescence
W38
C47
WB:P-JNK
WB:JNK1/2
WB: P-eIF2
WB: eIF2
WB: P-PERK
WB: PERK
25 uM PABA/NO 0.45 uM TG
0 2 4 6 12 24 4 12 24 (h)
WB:Chop
WB:Actin
0 2 4 6 24 (h)
WB:Bip
WB:LC3
20 uM PABA/NO
UPR-Induced Cell Death
Generation of S-glutathionylation refractory PDI (conversion of basic a.a. adjacent to catalytic cysteines to neutral)
WCGHCK
a domain
WCGHCK
a’ domain PDI-WT
WCGFCL WCGFCL PDI-FLFL
Histidine (H)
Lysine (K)
Phenylalanine
(F)
Leucine
(L)
Alanine
(A)
PDIFLFL is refractory to S-glutathionylation
WB: PDI
WB: P-SSG
In Vitro
In Cells
PABA/NO PDIWT
0 25 50 100
PDIFLFL
0 25 50 100 PDIWT PDIFLFL
- + - +
Rotenone
FLAG- PDIWT
FLAG- PDIFLFL
+ - + PABA/NO - +
Ctr
IP: FLAG
WB: PDI-PSSG
WB: PDI
WB: P-SSG
WB: PDI
Rotenone (µM) 0 250 500 1000 100
Rotenone (uM)
Mea
n O
.D.
0
2
4
6
0
5
10
0
2
4
P
DI
mR
NA
fold
incr
ease
- + - +
PDIWT PDIFLFL
- + - +
PDIWT PDIFLFL
- + - + PDIWT PDIFLFL
B
IP
mR
NA
fold
incr
ease
CH
OP
mR
NA
fold
incr
ease
S-glutathionylation refractory PDI
1) Blunts the toxic effects of rotenone
2) Diminishes activation of the UPR in
PC12 neuronal cells
Ueharal et al., Nature (2006) 441, 513-518
S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration
Takashi Uehara1,4, Tomohiro Nakamura1, Dongdong Yao1, Zhong-Qing Shi1, Zezong Gu1, Yuliang Ma2, Eliezer Masliah3, Yasuyuki Nomura4 and Stuart A. Lipton1,3
Grek, C and Townsend, D.M. (2013)
PDI is a chaperone for ERα What are the consequences of S-
glutahtionylation of PDI on ERα stability and transcriptional activation?
PDI: Chaperone for Estrogen Receptor alpha
Xiong, Y et al, Int J Cell Biol. 2012
ERα: hormone binding transcription factor Ligand binding domain DNA binding domain
DNA activation
Ross Weatherman: 2006: Nature Chemical Biology, 2, 175-176
Lin et al. Genome Biology (2004: 5:R6
PSSG
PDI
0 0.5 PABA/NO (h) 2
75
50
75
50
IP: PDI
75
50
0 0.5 PABA/NO (h) 2
IP: ERα
PDI
ERα
75
50
PDI-SSG blunts chaperone activity with ERα
Xiong et al., 2011. IJCB
ERα
Actin
MG132
PS341
DMSO
PABA/NO
+
+
+
+
+
+
+
-
+
-
+
-
-
-
-
-
-
-
-
-
-
-
-
-
0
50
100
150
200
0 2 4 8 (h)
ERα
Actin
A
C
B
Rela
tive
(%)
ERα
mRN
A
0
1
2
3
0 2h 8h
n=3
ERβ
RNS induce proteasomal degradation of ERα
Xiong, Y et al, Int J Cell Biol. 2012
0 2 4 8 (h)
E2 (20 nM)
ERα
Actin
ERβ
p21WAF1/CIP1
c-Myc
cyclin D1
0 2 4 8 (h)
PABA/NO (20 µM)
ERα
Actin
ERβ
p21WAF1/CIP1
cyclin D1
Cyclin D1 mRNA and protein were down-regulated by anti-estrogen ICI182780 (Faslodex). ICI182780 also increased the expression of the CDK inhibitor p21WAF1/CIP1 (Watts CK, et al. 1995)
PDI-SSG has anti-estrogen effects
Grek, C and Townsend, D.M. (2013)
ER stress is worth stressing over… ������
Parkinson’s
A
G
E
Huntington’s
Alzheimer's
Heart Disease
ER stress has been linked to the following medical conditions:
Acknowledgements • Townsend Lab
– Ying Xiong, Ph.D. – Zhiwei Ye, Ph.D. – Jordan Frederick, Ph.D. – Lin He – Tiffany Ancrum
• Yefim Manevich, Ph.D.
• Joachim Uys, Ph.D. • Novelos Therapeutics, Inc.
Christopher Pazoles, Ph.D. Harry Palmin, M.B.A.
NIH Funding: NIEHS: R56 ES017453
NIGM: GM103542-02
• Kenneth Tew, Ph.D., D.Sc. – Jie Zhang, Ph.D. – Robert Bowers, Ph.D. – Christina Grek, Ph.D. – Yian Chen, Ph.D.
• National Cancer Institute Larry Keefer, Ph.D.
Joseph Saavedra, Ph.D. Mahdol University, Thailand Chonticha Saisawang, Ph.D. Albert Ketterman, Ph.D.